Today on in-pharmatechnologist.com   Medgenics gets (bio)pumping CMC buys Lilly/ICOS facility Paraytec to lead biopharmaceutical sizing collaboration India's Glenmark pioneering through prioritising preclinical Almirall takes on big pharma in COPD

Related Industry News   Covance divests cardiac unit Exiqon enters cancer diagnostic field with Oncotech acquisition Addex and Merck target new cure for Parkinson's Pharmaceutical outsourcing: people on the move

		In association with
Breaking News on Pharmaceutical Technology
Daily  Tuesday 04 December 2007		Forward to a colleague

	Application Note Increase your lab productivity with Malvern's New Morphologi G3 particle characterization system The Morphologi® G3 automated particle characterization system from Malvern® Instruments is a new analytical tool that provides high quality, statistically significant particle size and shape information... Click Here Access Full Stories Medgenics gets (bio)pumping Medgenics' Biopump could be the solution to the issues surrounding protein therapy and is set to take on the $51bn US biopharmaceutical market after raising £3.28m ($6.76m) in funding in its Initial Public... Read CMC buys Lilly/ICOS facility Denmark-based CMC Biopharmaceuticals has snapped up Eli Lilly's recently acquired biologics facility for an undisclosed amount... Read Paraytec to lead biopharmaceutical sizing collaboration Paraytec has been chosen to lead a £1m (€1.4m) consortium project to develop new analytical instruments that will detect aggregation in biopharmaceutical processing... Read India's Glenmark pioneering through prioritising preclinical Glenmark is one of a handful of pharma firms in India pushing forward a preclinical programme as a priority... Read Almirall takes on big pharma in COPD Spanish firm Almirall is working on a new chronic obstructive pulmonary disease (COPD) treatment combined with a hi-tech easy use inhaler, creating what it hopes will be another competitive product from its in-house... Read
	All News Headlines for: December | November | October
	Application Note Transdermal Sufentanil Licensing Opportunity Aveva's 7-day sufentanil's advanced technology and patient benefits will enable Aveva and its Partner to capture a significant share of the existing $3.9 billion dollar chronic pain market... Click Here
	Related Industry News Covance divests cardiac unit Covance has announced the $35m sale of its electrocardiogram (ECG) unit in order to focus on its core businesses... Read Exiqon enters cancer diagnostic field with Oncotech acquisition Gene expression analysis expert Exiqon is to pay up to $45m (€30.7m) for diagnostics company Oncotech as a first step towards becoming a world leading miRNA diagnostic manufacturer... Read Addex and Merck target new cure for Parkinson's Merck & Co. has entered into an exclusive collaboration and licensing deal with Addex Pharma to develop a new class of orally available Parkinson's therapies... Read Pharmaceutical outsourcing: people on the move Patheon, Parexel, and others have all had people on the move in the world of pharmaceutical outsourcing... Read Weekly Comment No embryo required: human stem cells from the skin A startling breakthrough has allowed scientists to create human stem cells from just reprogrammed skin cells, with no embryo and thus, perhaps no ethical dilemma. Read Event Info Premier event for excipient manufacturers and end-users Europe's only dedicated forum on issues affecting the excipients sector is just two months away. Don't miss your chance to hear the latest on key topics such as supply chain integrity, counterfeiting, excipient master files and REACH... Click Here Previous Headlines Boehringer boosts biopharma base Boehringer Ingelheim has completed a hefty makeover of its biopharmaceutical production plant in Biberach, Germany... Read Pfizer plans more off-shoring and outsourcing Pfizer is looking to Asia for both R&D and manufacturing outsourcing and to help it cut costs in a bid to mitigate the effects of patent expiries and competition from generic drugs... Read Regeneron helps make Sanofi VelocImmune to its 'weak' pipeline Sanofi-Aventis recently admitted it needed to increase the number of biotech compounds in its pipeline and now, true to its word, the French pharma heavyweight has signed a big antibody deal with US biotech Regeneron... Read Pharmaceutical manufacturing: news in brief In-PharmaTechnologist.com brings you a selection of recent headlines from around the pharmaceutical manufacturing industry... Read Jubilant Organosys eyeing up European acquisitions Indian pharma services provider Jubilant Organosys is looking to buy up European contract research organisations (CRO) and contract research and manufacturing services (CRAMS) and it has got $100m to spend, according... Read Technical / White Papers, Case studies, Web casts Shop floor integration at Novartis Singapore - Case Study Product Information - brochures, Web centers Transdermal Sufentanil Licensing Opportunity - Application Notes Reproducible, homogeneous dry dispersions by the Morphologi® - Application Notes A Review of Dissolution tests with the Flow Through Method - Application Notes Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Cleanroom, safety equipment, supplies Contract services (outsourcing) Drug delivery systems Ingredients, excipients and raw materials IT solutions Lab equipment & consumables Packaging machinery & supplies Processing (automation, control, separation...) QA/QC & validation Tabletting, coating & ancillary equipment

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@In-PharmaTechnologist.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com